During the past decade, Innsbruck Universitaetsklinik conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 23 clinical trials were completed, i.e. on average, 59% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innsbruck Universitaetsklinik" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 20 trials, followed by "Gilead Sciences" with 6 trials sponsored, "Celgene" with 5 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Boston Scientific Corporation" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innsbruck Universitaetsklinik" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Sanofi" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator and "European Society of Surgical Oncology" with 2 trials as a collaborator. Other collaborators include 148 different institutions and companies that were collaborators in the rest 156 trials.

According to Clinical.Site data, the most researched conditions in "Innsbruck Universitaetsklinik" are "Leukemia" (6 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (6 trials), "Breast Cancer" (5 trials), "Crohn's Disease" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Innsbruck Universitaetsklinik" in a lesser frequency.

Most popular intervention types in "Innsbruck Universitaetsklinik" are "Drug" (72 trials), "Procedure" (16 trials), "Biological" (14 trials), "Radiation" (11 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "radiation therapy" (6 trials), "Filgotinib" (4 trials), "cytarabine" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Innsbruck Universitaetsklinik" are 88 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Innsbruck Universitaetsklinik". undefined are not yet recruiting, 9 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in Innsbruck Universitaetsklinik, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Innsbruck Universitaetsklinik, 7 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".